DOI: 10.1055/s-00000011

DMW - Deutsche Medizinische Wochenschrift

References

Nemeth G. et al.
Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial.

Lancet 2017;
389: 1103-1113

Nemeth G. et al.
Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial.

Lancet 2017;
389: 1103-1113

Download Bibliographical Data

Search in:
Access: